Phenotype characteristics of transgenic male mice expressing human aromatase under ubiquitin C promoter

被引:24
|
作者
Li, XD
Mäkelä, S
Streng, T
Santti, R
Poutanen, M
机构
[1] Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland
[2] Univ Turku, Inst Biomed, Dept Anat, FIN-20520 Turku, Finland
[3] Karolinska Inst, Novum, Dept Med Nutr, S-14157 Huddinge, Sweden
关键词
transgenic mice; estrogen; androgen; P450; aromatase;
D O I
10.1016/S0960-0760(03)00376-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To study the significance of the increased ratio of the estrogen/androgen concentration for the male reproductive functions, we have generated transgenic mice expressing human P450 aromatase under a promoter providing ubiquitous and permanent transgene expression (AROM+ mice). AROM+ male mice are characterized by elevated serum estradiol and prolactin (Prl) concentrations, combined with markedly reduced testosterone levels. The mice are present with a multitude of structural and functional alterations in the reproductive organs such as cryptorchidism, Leydig cell hyperplasia, disrupted spermatogenesis and infertility. Furthermore, the mice develop infravesical obstruction associated with the rhabdosphincter atrophy and rudimentary accessory sex glands. Interestingly, the mammary gland in AROM+ males undergo a ductal and alveolar development morphologically resembling terminally differentiated female mammary glands, and express several signaling proteins typical for female mammary glands. Some of the abnormalities seen in AROM+ mice are similar to those described in both mice and humans exposed to diethylstilbestrol (DES) in utero. The importance of the AROM+ model may lie in its predictability, i.e. the model suggests which abnormalities of the human reproductive functions may be associated with the increased ratio of estrogen/androgen concentrations in early life and at adult age as well. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 50 条
  • [21] Characterization of transgenic mice expressing EGFP under the control of the monkey 20α-hydroxysteroid dehydrogenase promoter
    Park, Chae-Won
    Jeong, Seong-Keun
    Nanjidsuren, Tsevelmaa
    Byambaragchaa, Munkhzaya
    Kang, Myung-Hwa
    Sim, Bo-Woong
    Min, Kwan-Sik
    SCIENCE CHINA-LIFE SCIENCES, 2018, 61 (08) : 966 - 974
  • [22] Characterization of transgenic mice expressing EGFP under the control of the monkey 20α-hydroxysteroid dehydrogenase promoter
    Chae-Won Park
    Seong-Keun Jeong
    Tsevelmaa Nanjidsuren
    Munkhzaya Byambaragchaa
    Myung-Hwa Kang
    Bo-Woong Sim
    Kwan-Sik Min
    Science China Life Sciences, 2018, 61 : 966 - 974
  • [23] Infravesical obstruction in aromatase over expressing transgenic male mice with increased ratio of serum estrogen-to-androgen concentration
    Streng, T
    Li, XD
    Lehtoranta, M
    Mäkelä, S
    Poutanen, M
    Talo, A
    Tekmal, RR
    Santti, R
    JOURNAL OF UROLOGY, 2002, 168 (01): : 298 - 302
  • [24] Characterization of transgenic mice expressing yellow fluorescent protein under the control of human SF1 promoter sequence.
    Cory, A
    Boyer, A
    Silversides, D
    BIOLOGY OF REPRODUCTION, 2005, : 239 - 239
  • [25] Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter
    Rochefort, P
    Caillou, B
    Michiels, FM
    Ledent, C
    Talbot, M
    Schlumberger, M
    Lavelle, F
    Monier, R
    Feunteun, J
    ONCOGENE, 1996, 12 (01) : 111 - 118
  • [26] The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice
    Schorpp, M
    Jager, R
    Schellander, K
    Schenkel, J
    Wagner, EF
    Weiher, H
    Angel, P
    NUCLEIC ACIDS RESEARCH, 1996, 24 (09) : 1787 - 1788
  • [27] Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
    Matsuoka, Y
    Vila, M
    Lincoln, S
    McCormack, A
    Picciano, M
    LaFrancois, J
    Yu, X
    Dickson, D
    Langston, WJ
    McGowan, E
    Farrer, M
    Hardy, J
    Duff, K
    Przedborski, S
    Di Monte, DA
    NEUROBIOLOGY OF DISEASE, 2001, 8 (03) : 535 - 539
  • [28] Induced diabetic phenotype in transgenic mice expressing the human Huntington's disease gene.
    Campfield, BA
    Wasmeier, C
    Smith, FJ
    Freed, CR
    Hutton, JC
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 69A - 69A
  • [29] Transgenic mice expressing a human apolipoprotein[a] allele
    Acquati, F
    Hammer, R
    Ercoli, B
    Mooser, V
    Tao, RX
    Rönicke, V
    Michalich, A
    Chiesa, G
    Taramelli, R
    Hobbs, HH
    Müller, HJ
    JOURNAL OF LIPID RESEARCH, 1999, 40 (06) : 994 - 1006
  • [30] ATHEROGENESIS IN TRANSGENIC MICE EXPRESSING HUMAN APOLIPOPROTEIN(A)
    LAWN, RM
    WADE, DP
    HAMMER, RE
    VERSTUYFT, JG
    RUBIN, EM
    CIRCULATION, 1992, 86 (04) : 335 - 335